Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.46 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5988356 | 0.86 | APOBEC3G (0.40) | APOBEC3GPDCD1CD274TSHRHPGD | |
| SCHEMBL309288 | 0.83 | APOBEC3G (0.38) | APOBEC3GPDCD1CD274TSHRCYP2A6 | |
| SCHEMBL10432946 | 0.80 | APOBEC3G (0.43) | APOBEC3GPDCD1CD274TSHRCYP2A6 | |
| SCHEMBL1674630 | 0.80 | GAA (0.45) | APOBEC3GPDCD1CD274TSHRGAA | |
| SCHEMBL4448098 | 0.80 | APOBEC3G (0.43) | APOBEC3GPDCD1CD274TSHRCYP2A6 | |
| SCHEMBL22639370 | 0.80 | CYP2C19 (0.39) | APOBEC3GPDCD1CD274TSHRALDH1A1 | |
| SCHEMBL5317695 | 0.77 | AR (0.46) | APOBEC3GPDCD1CD274TSHRALDH1A1 | |
| SCHEMBL41139 | 0.76 | APOBEC3G (0.60) | APOBEC3GPDCD1CD274TSHRCYP2A6 | |
| SCHEMBL29366632 | 0.76 | APOBEC3G (0.60) | APOBEC3GPDCD1CD274TSHRCYP2A6 | |
| SCHEMBL22639357 | 0.75 | S1PR1 (0.42) | APOBEC3GPDCD1CD274LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8591997-B2 | Process for preparing structured organic films (SOFS) via a pre-SOF | XEROX CORPORATION (US) | 2013-11-26 | — | — | US | claimed |
| US-9567425-B2 | Periodic structured organic films | XEROX CORPORATION (US) | 2017-02-14 | — | — | US | disclosed |
| US-20170022338-A1 | PERIODIC STRUCTURED ORGANIC FILMS | XEROX CORPORATION | 2017-01-26 | — | — | US | disclosed |
| EP-2403657-B1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORP (US) | 2016-12-28 | — | — | EP | disclosed |
| EP-2408572-B1 | COMPOSITE STRUCTURED ORGANIC FILMS | XEROX CORP (US) | 2016-12-21 | — | — | EP | disclosed |
| EP-2403858-B1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | XEROX CORP (US) | 2016-12-07 | — | — | EP | disclosed |
| EP-2403656-B1 | ELECTRONIC DEVICES COMPRISING A STRUCTURED ORGANIC FILM | XEROX CORP (US) | 2016-12-07 | — | — | EP | disclosed |
| EP-2403670-B1 | STRUCTURED ORGANIC FILMS | XEROX CORP (US) | 2016-11-16 | — | — | EP | disclosed |
| EP-2403655-B1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORP (US) | 2016-11-16 | — | — | EP | disclosed |
| US-9097995-B2 | Electronic devices comprising structured organic films | XEROX CORPORATION (US) | 2015-08-04 | — | — | US | disclosed |
| WO-2010102038-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| WO-2010102018-A1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| WO-2010102025-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| WO-2010102043-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100227157-A1 | COMPOSITE STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100228025-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227081-A1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100224867-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227071-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100224867-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | EPCAM, EPHA6, EED | APOBEC3G 1435/4885PDCD1 1330/4885CD274 869/4885 |
| US-20100228025-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | VIM, PUF60, EPCAM | APOBEC3G 1129/4885PDCD1 3366/4885CD274 2680/4885 |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | VIM, PUF60, EPCAM | APOBEC3G 1247/4885PDCD1 2539/4885CD274 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.